• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg
  • Home
  • Our people
  • Stockholm
  • Monica Lagercrantz

Monica Lagercrantz

  • Office: Stockholm
  • Position: Managing Partner | Advokat
  • Areas: Capital markets and public M&A Corporate Corporate finance

Monica is a member of the Capital market group and specializes in capital markets and corporate law. Monica advises clients in connection with various capital market transactions, and works regularly with capital raising, IPOs, incentive programmes, and general meetings. She lectures regularly about capital markets. Monica also has a broad experience of advising in relation to general corporate matters, corporate governance and regulatory matters on the equity capital markets, such as disclosure and market abuse matters.

Monica is together with Dennis Westermark the author of Om nyemission (Norstedts Juridik, 2013), and together with Dennis Westermark and Ola Svanberg the author of Om incitamentsprogram (Norstedts Juridik, 2019). Monica and Dennis are also the authors of the chapter on share issues in Börsrätt (Studentlitteratur, 4 u, 2017).

Monica is a member of the British-Swedish Chamber of Commerce.

Monica is managing partner at the Stockholm office.

 

Background

  • 2020– Lindahl law firm
  • 2010–2020 Advokatfirman Westermark Anjou
  • 2011 Member of the Swedish Bar Association
  • 2009 E. Öhman Fondkommission
  • 2006–2009 Advokatfirman Westermark Anjou
  • 2006 Stockholms University, LL.M.

Contact

monica.lagercrantz@lindahl.se +46 761 269 109 vCard

Related

  • 1/26/2023 4:13:04 PM Lindahl legal advisor to Sedana Medical AB (publ) in connection with a change of listing to Nasdaq Stockholm
  • 10/10/2022 5:04:40 PM Lindahl represents the Swedish cleantech company Plagazi AB (publ) with a procurement of capital amounting to approximately 53 MSEK
  • 3/29/2022 9:50:29 AM Lindahl assisted Bawat Water Technologies AB in connection with the company’s issue of units and listing on Nasdaq First North Premier Growth Market
  • 3/18/2022 10:48:27 AM Lindahl advisor to Transfer Group AB (publ) in connection with merger
  • 1/18/2022 6:04:18 PM Lindahl meets Monica Lagercrantz
  • 11/10/2021 9:59:46 AM The obligation to set up an insider list – a potential paradigm shift?
  • 10/12/2021 10:52:45 AM News in the field of Capital Markets
  • 8/2/2021 12:27:46 PM Lindahl has advised ISR Immune System Regulation Holding AB (publ) regarding investment agreement with Singapore Resources Development PTE. Ltd.
  • 6/9/2021 3:26:08 PM Lindahl has advised Biosergen AB in connection with the company’s issue of units and listing on Nasdaq First North Growth Market.
  • 4/13/2021 2:22:59 PM Lindahl advisor to Trainimal AB in connection with share issue and listing on NGM Nordic SME
  • 3/22/2021 3:13:01 PM Lindahl is assisting the Swedish greentech company Charge Amps AB in conjunction capital acquisition of SEK 130 million from Swedbank Robur
  • 1/27/2021 11:55:01 AM Lindahl assists the biotechnology company AegirBio in carrying out a multinational acquisition and merger
  • 1/13/2021 11:15:10 AM Lindahl continues to expand its Stockholm office by adding new partners
  • 10/22/2020 4:09:48 PM Lindahl assists Prevas AB in the acquisition of Evotech and subsidiaries
  • 10/13/2020 3:56:54 PM Lindahl assists Redsense Medical in a directed equity issue that infuses the company with around SEK 73 million
  • 10/9/2020 3:52:13 PM Lindahl assists Bredband2 i Scandinavia AB (plc) in a public takeover bid
  • 6/29/2020 3:59:04 PM Lindahl assists ISR Immune System Regulation Holding in a targeted new share issue worth MSEK 5
  • 6/1/2020 4:41:50 PM Lindahl represents Aegirbio in rights issue of units prior too listing on Nasdaq First North Growth Market
  • 5/6/2020 5:17:13 PM Lindahl assists ISR Immune System Regulation Holding in a rights issue of approximately SEK 71.7 million

Search employee

315 employees
  • Johan Åberg johan.aberg@lindahl.se +46 761 269 105
  • Felicia Åberg felicia.aberg@lindahl.se +46 723 571 456
  • David Ackebo david.ackebo@lindahl.se +46 701 474 119
  • Anders Adielsson anders.adielsson@lindahl.se +46 730 399 253
  • Tobias Adolfsson
  • Philip Ahl philip.ahl@lindahl.se +46 731 472 711
  • Gustav Ahlgren gustav.ahlgren@lindahl.se +46 734 158 215
  • Disa Almqvist disa.almqvist@lindahl.se +46 708 621 453
  • Simon Alsing simon.alsing@lindahl.se +46 723 937 521
  • Sara Andersson sara.andersson@lindahl.se +46 709 896 523
  • Annika Andersson annika.andersson@lindahl.se +46 730 399 240
  • Ida Andersson
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience